W Lee Maloy

This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Biologically Active Peptides. Top assignees: Genaera Corporation, Magainin Pharmaceuticals, Inc., Ohr Pharmaceutical Inc.. Active years: 1993-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: W Lee Maloy. Retrieved from https://idiyas.com/inventor/w-lee-maloy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 5)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 182(Granted Patents)

Location History:

Landsdale, PA (US) (2001)
Plymouth Meeting, PA (US) (2003 - 2007)
Lansdale, PA (US) (1993 - 2022)

Company Filing History:

Magainin Pharmaceuticals, Inc.

patents

2 out of 6

Ohr Pharmaceutical Inc.

patents

4. 2 out of 301

The Children's Hospital of Philadelphia

Years Active: 1993-2022

Loading Chart...

Areas of Expertise:

Aminosteroids

PTP1B

Interleukin-9

Peptide Compositions

Chloride Channel

Asthma Treatment

Biologically Active

Antimicrobial Peptides

Gynecological Malignancies

Ion-Channel Forming

D-Amino Acids

Mutein Peptides

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11434257 - Aminosteroids for the treatment of a PTP1B associated disease (2022-09-06),

2. 10556923 - Aminosteroids for the treatment of a PTP1B associated disease (2020-02-11),

3. 9546194 - Aminosteroids for the treatment of a PTP1B associated disease (2017-01-17),

4. 7700088 - Interleukin-9 mutein peptides (2010-04-20),

5. 7211254 - Methods for treating ICACC protein associated diseases (2007-05-01),

6. 7192578 - Interleukin-9 mutein peptides (2007-03-20),

7. 6716603 - Nucleic acids encoding a chloride channel protein (2004-04-06),

8. 6645492 - Methods of treating asthma with interleukin-9 receptor antibodies (2003-11-11),

9. 6576434 - Methods for identification of agents which modulate chloride channel activity (2003-06-10),

10. 6261559 - Methods of treating asthma with interleukin-9 antibodies (2001-07-17),

11. 5792831 - Analogues of magainin peptides containing D-amino acids (1998-08-11),

12. 5635479 - Treatment of gynecological malignancies with biologically active peptides (1997-06-03),

13. 5620954 - Peptide compositions and uses therefor (1997-04-15),

14. 5470950 - Biologically active amphiphilic peptide compositions and uses therefor (1995-11-28),

15. 5459237 - Peptide compositions and uses therefor (1995-10-17),

Title: W Lee Maloy: A Pioneer in Aminosteroid Innovations

W Lee Maloy is a distinguished inventor based in Lansdale, Pennsylvania, with a remarkable portfolio of 18 patents to his name. His contributions to the field of pharmaceuticals, particularly in the area of aminosteroids, have garnered attention and respect within the scientific community.

Latest Patents

Among W Lee Maloy's most notable recent patents is his work on "Aminosteroids for the treatment of a PTP1B associated disease." This innovative application focuses on the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in mammals, notably aiming for advancements in the treatment of diabetes. This significant research offers potential new avenues for therapeutic intervention in metabolic diseases, highlighting Maloy's commitment to addressing critical health challenges.

Career Highlights

Throughout his career, W Lee Maloy has made substantial contributions while working with reputable organizations, including Genaera Corporation and Magainin Pharmaceuticals, Inc. His tenure at these companies has allowed him to apply his inventive prowess in practical settings, resulting in significant advancements in medical science and pharmaceutical solutions.

Collaborations

W Lee Maloy has collaborated with esteemed colleagues, including Roy Clifford Levitt and Nicholas C Nicolaides. These partnerships have fostered a creative environment that encourages innovation, enabling impactful research and development in the biotechnology landscape.

Conclusion

In conclusion, W Lee Maloy has made significant strides in pharmaceutical research, particularly with his focus on aminosteroids and their applications in treating diabetes. His notable patents and collaborations reflect his dedication and influence in the field. As he continues to innovate, Maloy remains a vital figure in the advancement of medical therapies.

Profile summary based on public USPTO records.